Latest Regentis Biomaterials News & Updates

See the latest news and media coverage for Regentis Biomaterials. We track all announcements, press releases, and industry mentions in real time, all in one place.

Regentis Biomaterials

Hydrogel implant developer for tissue repair

regentis.co.il

Headquarters: Herzliya, Israel
Company type: Public company
Number of employees: 10–50
Industry: Medical Equipment, Supplies & Distribution

Last updated Today

Latest news about Regentis Biomaterials

In short: Regentis Biomaterials expanded its GelrinC intellectual property and manufacturing capacity while advancing clinical trials and training.

Company announcements

July 22 Regentis Biomaterials

Regentis Biomaterials receives Japanese patent allowance

The patent covers proprietary manufacturing technology for its GelrinC product, enhancing its global intellectual property portfolio.

July 2 Regentis Biomaterials

Regentis Biomaterials completes physician training for GelrinC in Milan

Orthopedic surgeons gained hands-on experience with the cartilage repair technology during the session at Humanitas.

June 4 Regentis Biomaterials

Regentis Biomaterials discusses potential of GelrinC platform.

GelrinC could become the first widely adopted off-the-shelf regenerative cartilage repair platform.

May 18 Regentis Biomaterials

Regentis Biomaterials develops and patents new manufacturing process

The solvent-free process increases GelrinC production yield by 400%.

Media coverage

July 15 USA Today

Regentis Biomaterials (NYSE American: RGNT) Receives European Approval for Next-Generation GelrinC Manufacturing Process

Regentis Biomaterials (NYSE American: RGNT) announced it has received approval from the European Notified Body to...

June 17 The Desert Sun

Regentis' GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted Method

HERZLIYA, IL / ACCESS Newswire / January 20, 2026 / Regentis Biomaterials Ltd., ("Regentis" or the "Company") (NYSE American:RGNT), a regenerative medicine company focused on...

June 15 The Globe and Mail

Regentis Biomaterials Appoints Chairman Ehud Geller as CEO After Hazum Resignation

Detailed price information for Regentis Biomaterials Ltd (RGNT-A) from The Globe and Mail including charting and trades.

June 15 USA Today

Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement

HERZLIYA, IL / ACCESS Newswire / June 17, 2026 / Regentis Biomaterials Ltd. ("Regentis" or the "Company") (NYSE...

Never miss news about Regentis Biomaterials

Track Regentis Biomaterials and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.